|Times Cited||Cited Author||Cited work||SRCosmos Link|
|Citations by articles in Journals|
|1||LUO W...||Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, |
ET AL. Phospholamban gene dosage effects in the mammalian heart. Circ Res 1996, 78:839---847.
|1||LUO W...||Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, |
ET AL. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of betaagonist stimulation. Circ Res 1994, 75:401---409.
|1||...Luo W||Wolska BM, Stojanovic MO, Luo W, Kranias EG, Solaro RJ, |
Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca 2+ . Am J Physiol 1996, 271(1 Pt 1):C391---C397.
|1||...Luo W||Kiss E, Edesi I, Sato Y, Luo W, Liggett SB, Kranias EG, |
beta-adrenergic regulation of cAMP and protein phosphorylation in phospholambanknockout mouse hearts. Am J Physiol 1997, 272(2 Pt 2):H785---H790.
|1||LUO W...||Luo W, Chu G, Sato Y, Zhou Z, Kadambi VJ, Kranias EG, |
Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J Biol Chem 1998, 273:4734---4739.
|Citations by articles in Conferences|
|1||LUO W...||Luo W, Wang F, |
2003, Measures of spatial accessibility to health care in a GIS environment: synthesis and a case study in the Chicago region, Environment and Planning B, 30, pp. 865 – 884.